ImmunityBio subsidiary to enforce settlement as Sorrento fails to pay judgments

ImmunityBio, Inc.

Sorrento failed to pay judgments held by NantCell and NANTibody by August 31, 2023 deadline.
NantCell and NANTibody to deliver certification of non-payment by September 6, triggering settlement terms.
Upon certification, mutual release of claims, release of judgments, and Sorrento relinquishes NANTibody interests.
Sorrento forfeits rights to payments from antibody license including royalties from PD-L1 t-haNK NK cell therapy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.